VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACGL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACGLArch Capital Group Ltd.
$98.06$34.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACGLQuarterly Financials

Arch Capital Group Ltd. (ACGL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Arch Capital Group Ltd. (ACGL) quarterly income statement — complete revenue, gross profit & net income history

ACGL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue4.36B5.39B4.98B4.97B4.59B5.02B4.48B4.06B3.88B3.79B3.29B3.1B3.12B2.95B2.49B2.27B1.95B2.25B2.04B2.43B
Revenue Growth %-5.03%7.31%11.09%22.43%18.41%32.56%36.05%31.2%24.37%28.3%32.2%36.51%60.23%31.1%22.33%-6.58%-11.97%1.19%-4.8%4.49%
Medical Costs & Claims2.09B3.06B2.99B3.13B3.35B3.11B3.08B2.46B2.33B2.28B2.22B2.05B2B1.74B2.13B1.52B1.38B1.35B1.53B1.49B
Medical Cost Ratio %47.9%56.78%60%62.88%72.97%62.03%68.84%60.56%60.21%60.21%67.48%66.28%64.27%59.01%85.55%66.84%70.86%60.11%75.24%61.58%
Gross Profit2.27B2.33B1.99B1.85B1.24B1.91B1.4B1.6B1.54B1.51B1.07B1.04B1.11B1.21B360M752M567M898.12M504.29M932.78M
Gross Margin %52.1%43.22%40%37.12%27.03%37.97%31.16%39.44%39.79%39.79%32.52%33.72%35.73%40.99%14.45%33.16%29.14%39.89%24.76%38.42%
Gross Profit Growth %83.08%22.14%42.62%15.23%-19.57%26.48%30.35%53.45%38.51%24.56%197.5%38.83%96.47%34.71%-28.61%-19.38%-19.34%6.56%-25.26%11.28%
Operating Expenses1.13B941M488M435M563M703M346M448M476M421M389M399M420M362.75M347M389M418M347.81M308.26M309.6M
OpEx / Revenue %25.84%17.47%9.81%8.75%12.26%14%7.72%11.03%12.27%11.12%11.81%12.89%13.47%12.29%13.93%17.15%21.48%15.45%15.14%12.75%
Depreciation & Amortization30M47M49M48M49M99M88M27M21M24M24M24M23M25.72M26M27M27M33.13M20.14M15.29M
Combined Ratio %73.74%74.25%69.8%71.63%85.24%76.04%76.56%71.59%72.49%71.32%79.29%79.17%77.74%71.3%99.48%83.99%92.34%75.56%90.37%74.33%
Operating Income1.15B1.39B1.5B1.41B678M1.2B1.05B1.15B1.07B1.09B682M645M694M847.13M13M363M149M550.31M196.03M623.18M
Operating Margin %26.26%25.75%30.2%28.37%14.76%23.96%23.44%28.41%27.51%28.68%20.71%20.83%22.26%28.7%0.52%16.01%7.66%24.44%9.63%25.67%
Operating Income Growth %68.88%15.3%43.14%22.27%-36.46%10.77%53.96%78.91%53.75%28.2%5146.15%77.69%365.77%53.94%-93.37%-41.75%-59.45%1.14%-49.05%11.12%
EBITDA1.18B1.43B1.55B1.46B727M1.3B1.14B1.18B1.09B1.11B706M669M717M872.85M39M390M176M583.44M216.17M638.47M
EBITDA Margin %26.94%26.62%31.18%29.34%15.83%25.94%25.4%29.07%28.06%29.31%21.44%21.61%23%29.57%1.57%17.2%9.04%25.91%10.62%26.3%
Interest Expense37M38M37M38M35M37M35M35M34M34M34M33M32M31.7M33M33M33M32.25M33.18M35.7M
Non-Operating Income-37M-70M-37M-38M-35M229M-35M-202M-133M-136M-93M-102M-80M-72.05M-14M-91M-69M-99.38M-138.57M-157.89M
Pretax Income1.15B1.45B1.56B1.45B695M1B1.09B1.37B1.22B1.26B795M736M781M923.71M3M426M210M658.08M425.55M769.84M
Pretax Margin %26.26%26.88%31.44%29.18%15.14%19.94%24.24%33.63%31.49%33.19%24.14%23.77%25.05%31.29%0.12%18.78%10.79%29.23%20.9%31.71%
Income Tax98M210M215M214M121M66M98M97M101M-1.08B72M67M64M60.92M-15M22M12M34.41M4.14M51.18M
Effective Tax Rate %8.56%14.5%13.74%14.75%17.41%6.59%9.02%7.1%8.27%-85.6%9.06%9.1%8.19%6.6%-500%5.16%5.71%5.23%0.97%6.65%
Net Income1.05B1.24B1.35B1.24B574M935M988M1.27B1.12B2.33B723M671M715M859.69M17M404M196M623.26M419.94M675.49M
Net Margin %24.01%22.98%27.12%24.87%12.5%18.63%22.05%31.24%28.88%61.63%21.96%21.67%22.93%29.12%0.68%17.81%10.07%27.68%20.62%27.82%
Net Income Growth %82.4%32.41%36.64%-2.52%-48.75%-59.94%36.65%89.12%56.64%171.49%4152.94%66.09%264.8%37.93%-95.95%-40.19%-55.27%14.67%0.22%126.05%
EPS (Diluted)2.883.353.563.231.482.412.563.302.926.121.881.751.872.320.021.040.481.580.981.63
EPS Growth %94.59%39%39.06%-2.12%-49.32%-60.62%36.17%88.57%56.15%163.79%9300%68.27%289.58%46.84%-97.96%-36.2%-54.29%21.54%-2%129.58%
EPS (Basic)2.883.403.633.301.512.482.623.382.996.291.931.791.922.320.021.070.501.621.001.67
Diluted Shares Outstanding359.7M376.1M376.1M379.9M381.9M381.8M382.3M381.6M380.5M379.8M379.4M378.4M377.6M365.9M373.73M377.95M384.19M388.87M397.9M406.49M